Clinical Trials Directory

Trials / Completed

CompletedNCT05421832

A Novel Measurement Concept to Objectively Quantify Severity of Vocal and Speech Related Symptoms Associated With Parkinson's Disease

Status
Completed
Phase
Study type
Observational
Enrollment
91 (actual)
Sponsor
Northwestern University · Academic / Other
Sex
All
Age
30 Years
Healthy volunteers
Accepted

Summary

The aim of this research program is to develop and validate a smartphone app-based digital measurement concept that: * Objectively quantifies the severity of Parkinson's Disease (PD) related vocal and speech symptoms; * Accurately and sensitively identifies vocal and speech abnormalities associated with the prodromal stage of PD.

Detailed description

Although multiple approaches to this problem have been proposed in addition to commercially available speech analytics platforms, there is currently no established measure which incorporates the disparate aspects of affected speech to fully characterize Parkinson's symptom progression, particularly in the prodromal phase. The measurement concept being evaluated in the present study utilizes a custom smartphone-based speech assessment tool to extract multiple hypothesis-driven acoustic features from patient speech in a real-life environment. The resultant features will be used to train a pair of supervised machine learning models to predict clinical PD symptom severity scores, and to distinguish prodromal PD patients from both healthy matched controls and PD patients in more advanced phases of disease progression.

Conditions

Interventions

TypeNameDescription
DEVICEDigital Speech ApplicationA custom smartphone-based speech assessment tool to extract multiple hypothesis-driven acoustic features from patient speech in a real-life environment.

Timeline

Start date
2022-09-27
Primary completion
2025-06-30
Completion
2025-06-30
First posted
2022-06-16
Last updated
2025-07-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05421832. Inclusion in this directory is not an endorsement.

A Novel Measurement Concept to Objectively Quantify Severity of Vocal and Speech Related Symptoms Associated With Parkin (NCT05421832) · Clinical Trials Directory